Our Compounding

Therapeutic Category:

Antiplatelet Agent

Key Ingredients:

Clopidogrel - an active thiol metabolite irreversibly blocks the P2Y12 component of ADP receptors on platelet surface, prevents activation of the GPIIb/IIIa receptor complex, thereby reducing platelet aggregation .Platelet blocked by clopidogrel are affected for the remainder of their lifespan (~7-10 days)

Formulation Strength:

Clopidogrel Suspension 5mg/ml

Pediatric Oral:

• Neonatal / pediatric antiplatelet

May be taken without regard to meals.